Clinical dose findings of sitafloxacin treatment: pharmacokinetic-pharmacodynamic analysis of two clinical trial results for community-acquired respiratory tract infections

Author： Kohno Shigeru  

Publisher： Springer Publishing Company

ISSN： 1341-321X

Source： Journal of Infection and Chemotherapy, Vol.19, Iss.3, 2013-06, pp. : 486-494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics of telithromycin: application to dosing in the treatment of community-acquired respiratory tract infections

By Ciervo Carman A.   Shi Jun  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1641-1650

Informa Healthcare

Access to resources Recommend Favorite

Clinical and bacteriological efficacies of sitafloxacin against community-acquired pneumonia caused by Streptococcus pneumoniae : nested cohort within a multicenter clinical trial

By Fujita Jiro  

Journal of Infection and Chemotherapy, Vol. 19, Iss. 3, 2013-06 ,pp. : 472-479

Springer Publishing Company

Access to resources Recommend Favorite

Update on the use of the macrolides for community-acquired respiratory tract infections

By Blondeau Joseph M  

Therapy, Vol. 3, Iss. 5, 2006-09 ,pp. : 619-650

Future Medicine

Access to resources Recommend Favorite

Therapeutic Implications of Antibacterial Resistance in Community-Acquired Respiratory Tract Infections in Children

By Cunha B.  

Infection, Vol. 32, Iss. 2, 2004-04 ,pp. : 98-108

Springer Publishing Company

Access to resources Recommend Favorite

Application of Pharmacokinetics and Pharmacodynamics to Antimicrobial Therapy of Community-Acquired Respiratory Tract Infections

By  

Respiration, Vol. 72, Iss. 6, 2005-12 ,pp. : 561-571

Karger

Access to resources Recommend Favorite